SEATTLE, Nov. 10 /PRNewswire-FirstCall/ -- On Monday, November 14, 2005, at 9:00 a.m. Eastern/6:00 a.m. Pacific time, members of Cell Therapeutics, Inc.'s (CTI) management team will host a quarterly conference call to discuss the Company’s 2005 third quarter achievements and financial results.
According to the Form NT 10-Q filed by CTI on November 9, CTI’s 10Q quarterly report was delayed to allow its independent auditor, Stonefield Josephson, Inc., which was appointed on October 14, 2005, to complete their review of the Company’s unaudited financial statements. CTI anticipates filing the 10-Q for the period ended September 30, 2005, along with its unaudited financials statements, on November 14, within the allowed extension period. All of the Company’s other required periodic reports have been filed in a timely manner and the Company does not anticipate any significant change in results of operations from the corresponding period for the last fiscal year.
Third Quarter Financial Conference Call Monday, November 14 9:00 a.m. Eastern/6:00 a.m. Pacific 1-888-385-9734 (US Participants) 1-773-756-4818 (International) Passcode: CTIC Live audio webcast at www.cticseattle.com Will be archived for post listening approximately 2 hours after call ends Call-back numbers for post listening: 1-800-839-3139 1-203-369-3126 Passcode: CTIC
Cell Therapeutics, Inc.
CONTACT: investors, Leah Grant, +1-206-282-7100, or fax, +1-206-272-4434,or invest@ctiseattle.com, or media, Susan Callahan, +1-206-272-4472, orfax, +1-206-272-4434, or media@ctiseattle.com, both of Cell Therapeutics,Inc.
